BMJ  2007;335:357-358 (25 August), doi:10.1136/bmj.39302.707998.AE

Editorials

Human papillomavirus vaccination programmes

Need to have a broader perspective than simply increasing uptake of the vaccine

The first 150 words of the full text of this article appear below.

Human papillomavirus (HPV) vaccine is a scientific and public health breakthrough in the prevention of cervical cancer. In an analysis article in this week's BMJ, Raffle argues that HPV vaccination must be part of a comprehensive, integrated system of cervical cancer prevention.¹ She emphasises that public health policy should be data driven, and several outcomes of an HPV vaccination programme must be assessed, including uptake, follow-up screening, cancer incidence, and cost effectiveness.

Therefore, a successful HPV vaccination programme requires more than just a series of injections. A still broader perspective would also tackle the controversial matters of adolescent sexuality, parental control, and protection of children. HPV vaccine should be given before exposure to the virus. Ethical and political dilemmas arise because some parents may not want to consider the possibility that their daughters might initiate sexual intercourse at an early age.

Responding to individuals who decide against participation in . . . [Full text of this article]

521 Parnassus Avenue, San Francisco, CA 94143-0903

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Challenges of implementing human papillomavirus (HPV) vaccination policy

Angela E Raffle
BMJ 2007 335: 375-377. [Extract] [Full Text] [PDF]

Commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adopted

Eduardo L Franco
BMJ 2007 335: 378-379. [Extract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Why target only women for HPV prevention

Joseph More
bmj.com, 24 Aug 2007 [Full text]

Re: Why target only women for HPV prevention

Steven Ford
bmj.com, 4 Sep 2007 [Full text]